TherapeuticsMD (TXMD) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
TherapeuticsMD Announces First Quarter 2019 Financial Results
May 6, 2019 4:05 PM EDTBIJUVA Commercial Launch in April 2019
Completed $300 Million Non-Dilutive Term Loan Financing Facility in April 2019
IMVEXXY® Continues Strong Positive Trends for Prescriptions and Patient Refills
Conference Call Scheduled for 4:30 p.m. ET Today
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading womens healthcare company, today announced its commercial and corporate update for the first quarter ended March 31, 2019.
We are pleased with our recent progress on achieving several business objectives, which include the on-time launch of... More
